Ozenoxacin-d3 hydrochloride

• CAT Number: I042364
• Molecular Formula: C21H19D3ClN3O3
• Molecular Weight: 402.89
• Purity: ≥95%
• Synonyms: 1-cyclopropyl-8-methyl-7-[5-methyl-6-(trideuteriomethylamino)pyridin-3-yl]-4-oxoquinoline-3-carboxylic acid;hydrochloride
• InChI: InChI=1S/C21H21N3O3.ClH/c1-11-8-13(9-23-20(11)22-3)15-6-7-16-18(12(15)2)24(14-4-5-14)10-17(19(16)25)21(26)27;/h6-10,14H,4-5H2,1-3H3,(H,22,23)(H,26,27);1H/i3D3
• InChIKey: UKHHULMETIGXKF-FJCVKDQNSA-N
• SMILES: [2H]C([2H])([2H])NC1=NC=C(C=C1C)C2=C(C3=C(C=C2)C(=O)C(=CN3C4CC4)C(=O)O)C.Cl

Ozenoxacin-d3 hydrochloride（Cat No.:I042364）is a deuterated form of ozenoxacin, an antibiotic used to treat skin infections, particularly impetigo caused by Staphylococcus aureus and Streptococcus pyogenes. The “d3” refers to the incorporation of three deuterium atoms (heavy hydrogen isotopes) in the molecule, which is useful in pharmacokinetic and metabolic studies. This modification allows researchers to trace the compound’s behavior in the body, distinguishing it from the non-deuterated form. Ozenoxacin-d3 hydrochloride is mainly used in scientific research to evaluate the pharmacodynamics and pharmacokinetics of ozenoxacin and its therapeutic efficacy.